Is neoadjuvant immunotherapy feasible for patients with dMMR/MSI−H locally advanced colorectal cancer? a retrospective study
BackgroundNeoadjuvant immunotherapy has demonstrated satisfactory efficacy for high microsatellite instability/mismatch repair deficiency (dMMR/MSI-H) in locally advanced colorectal cancer (LACRC). This study aims to evaluate the safety and short-term efficacy of neoadjuvant immunotherapy for patien...
Saved in:
| Main Authors: | Zhenkai Luo, Danjun Wang, Zhexue Wang, Hang Zhao, Renshen Xiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1645412/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research progress of immune checkpoint inhibitors in neoadjuvant immunotherapy for dMMR/MSI-H locally advanced colorectal cancer
by: Zhu Xi, et al.
Published: (2024-02-01) -
Negative response to immunotherapy in dMMR or MSI-H gastric cancer with APC and PTEN mutations: a case report
by: Jiang Liu, et al.
Published: (2024-11-01) -
Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
by: Yupeng Jiang, et al.
Published: (2025-02-01) -
Case Report: Pathological complete response achieved with neoadjuvant immunochemotherapy in synchronous multiple gastric adenocarcinoma
by: Ya-hui Sun, et al.
Published: (2025-07-01) -
Updates on DNA Repair Gene Deficiency in Colorectal Cancer (dMMR)
by: Gustavo Sevá-Pereira, et al.
Published: (2025-03-01)